ARCHIVES

Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

February 6, 2004

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

National Action Plan: Steering committee Votes No Confidence In HHS Official.

August 15, 1997

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

January 31, 1992

Hatfield Asks AACR to Join In forming “Triangle Coalition”

June 23, 1989